Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CREBBP | Q92793 | 14/20 | 0.46 |
| ▸ | BRD4 | O60885 | 5/20 | 0.40 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.37 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.36 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31489519 | 1.00 | CREBBP (0.46) | CREBBPBRD4PDK2GPR55NR3C2 | |
| SCHEMBL31489462 | 0.89 | CREBBP (0.49) | CREBBPBRD4PDK2 | |
| SCHEMBL31489263 | 0.85 | CREBBP (0.46) | CREBBPBRD4GPR55CYP17A1 | |
| SCHEMBL31489746 | 0.84 | CYP17A1 (0.38) | CREBBPPDK2NR3C2CYP17A1 | |
| SCHEMBL31489590 | 0.84 | CYP17A1 (0.38) | CREBBPPDK2NR3C2CYP17A1 | |
| SCHEMBL31489229 | 0.83 | PDK2 (0.36) | CREBBPPDK2 | |
| SCHEMBL31489182 | 0.83 | PDK2 (0.36) | CREBBPPDK2 | |
| SCHEMBL31489347 | 0.78 | CREBBP (0.42) | CREBBPBRD4GPR55CYP17A1 | |
| SCHEMBL31489258 | 0.78 | CREBBP (0.42) | CREBBPBRD4GPR55CYP17A1 | |
| SCHEMBL31489687 | 0.77 | CREBBP (0.43) | CREBBPBRD4GPR55CYP17A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072395-A1 | TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-04-03 | — | — | WO | disclosed |